Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

329 ARTÍCULOS , VIENDO DEL 151 AL 165

The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms

Lương Kv, Nguyen LT.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):427-39. doi: 10.1177/1533317513488924. Epub 2013 May 20.

Cerebrovascular contributions to Alzheimer's disease pathophysiology and potential therapeutic interventions in mouse models

Thomason LA, Stefanovic B, McLaurin J.

Eur J Neurosci. 2013 Jun;37(12):1994-2004. doi: 10.1111/ejn.12181.

Trafficking in neurons: searching for new targets for Alzheimer's disease future therapies

Musardo S, Saraceno C, Pelucchi S, Marcello E.

Eur J Pharmacol. 2013 Nov 5;719(1-3):84-106. doi: 10.1016/j.ejphar.2013.07.019. Epub 2013 Jul 23.

Immunotherapy for Alzheimer's disease

Farlow MR, Brosch JR.

Neurol Clin. 2013 Aug;31(3):869-78. doi: 10.1016/j.ncl.2013.03.012. Epub 2013 May 18.

[Alzheimer's disease and geriatric eye diseases in the aspect of amyloid genesis]

Ermilov VV, Tiurenkov IN, Nesterova AA, Zagrebin VA.

Arkh Patol. 2013 Mar-Apr;75(2):37-42.

Preclinical trials in autosomal dominant AD: implementation of the DIAN-TU trial

Mills SM, Mallmann J, Santacruz AM, Fuqua A, Carril M, Aisen PS, Althage MC, Belyew S, Benzinger TL, Brooks WS, Buckles VD, Cairns NJ, Clifford D, Danek A, Fagan AM, Farlow M, Fox N, Ghetti B, Goate AM, Heinrichs D, Hornbeck R, Jack C, Jucker M, Klunk WE, Marcus DS, Martins RN, Masters CM, Mayeux R, McDade E, Morris JC, Oliver A, Ringman JM, Rossor MN, Salloway S, Schofield PR, Snider J, Snyder P, Sperling RA, Stewart C, Thomas RG, Xiong C, Bateman RJ.

Rev Neurol (Paris). 2013 Oct;169(10):737-43. doi: 10.1016/j.neurol.2013.07.017. Epub 2013 Sep 6.

Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents

Amiri H, Saeidi K, Borhani P, Manafirad A, Ghavami M, Zerbi V.

ACS Chem Neurosci. 2013 Nov 20;4(11):1417-29. doi: 10.1021/cn4001582. Epub 2013 Sep 26.

Current concepts in Alzheimer's Disease: molecules, models and translational perspectives

Rutten BP, Steinbusch HW.

Mol Neurodegener. 2013 Oct 22;8:33. doi: 10.1186/1750-1326-8-33.

[Development of therapies for Alzheimer's disease based on cholinergic hypothesis-status quo and future directions]

Shimohama S.

Rinsho Shinkeigaku. 2013;53(11):1036-8. doi: 10.5692/clinicalneurol.53.1036.

Light therapy and Alzheimer's disease and related dementia: past, present, and future

Hanford N, Figueiro M.

J Alzheimers Dis. 2013;33(4):913-22. doi: 10.3233/JAD-2012-121645.

Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease

Zhu CW, Livote EE, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y.

Alzheimers Dement. 2013 Nov;9(6):733-40. doi: 10.1016/j.jalz.2012.09.015. Epub 2013 Jan 17.

Potentially inappropriate medication use among patients with Alzheimer disease in the REAL.FR cohort: be aware of atropinic and benzodiazepine drugs!

Montastruc F, Gardette V, Cantet C, Piau A, Lapeyre-Mestre M, Vellas B, Montastruc JL, Andrieu S; REAL.FR Group.

Eur J Clin Pharmacol. 2013 Aug;69(8):1589-97. doi: 10.1007/s00228-013-1506-8. Epub 2013 Apr 16.

Effects of the Finnish Alzheimer disease exercise trial (FINALEX): a randomized controlled trial

Pitkälä KH, Pöysti MM, Laakkonen ML, Tilvis RS, Savikko N, Kautiainen H, Strandberg TE.

JAMA Intern Med. 2013 May 27;173(10):894-901. doi: 10.1001/jamainternmed.2013.359.

Memantine is associated with longer survival than donepezil in a Veterans Affairs prescription database, 1997 to 2008

Lazzeroni LC, Halbauer JD, Ashford JW, Noda A, Hernandez B, Azor V, Hozack N, Hasson N, Henderson VW, Yesavage JA, Tinklenberg JR.

J Alzheimers Dis. 2013;36(4):791-8. doi: 10.3233/JAD-130662.

Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study

Laroche ML, Perault-Pochat MC, Ingrand I, Merle L, Kreft-Jais C, Castot-Villepelet A, Durrieu G, Gras V, Guy C, Jean-Pastor MJ, Jonville-Béra AP, Merlet-Chicoine I, Miremont-Salamé G, Nourhashemi F, Charmes JP; French Centres of Pharmacovigilance Network.

Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):952-60. doi: 10.1002/pds.3471. Epub 2013 Jun 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias